US Patent Issued to SK CHEMICALS, STANDIGM on April 7 for "Composition for preventing or treating TNF-Alpha-related disease, comprising hydroflumethiazide as active ingredient" (South Korean Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,279, issued on April 7, was assigned to SK CHEMICALS Co. LTD. (Seongnam-si, South Korea) and STANDIGM INC. (Seoul, South Korea).

"Composition for preventing or treating TNF-Alpha-related disease, comprising hydroflumethiazide as active ingredient" was invented by Soo Min Lee (Seongnam-si, South Korea), Jong-In Kim (Seongnam-si, South Korea), Nam-Jin Gu (Seongnam-si, South Korea), Jeong-Hoon Kim (Seongnam-si, South Korea), Dae Hee Han (Seoul, South Korea) and Hee Jung Koo (Seoul, South Korea).

According to the abstract* released by the U.S. Patent & Trademark Office: "A composition for preventing or treating a TNF-Alpha-related disease is disclosed. The composition includes hydrof...